Medicine & Life Sciences
Schizophrenia
100%
Antipsychotic Agents
59%
Electroconvulsive Therapy
37%
Psychotic Disorders
36%
Depression
23%
Psychiatry
22%
Mental Health
19%
Olanzapine
18%
Therapeutics
17%
Sleep Initiation and Maintenance Disorders
15%
Meta-Analysis
15%
Post-Traumatic Stress Disorders
14%
Tardive Dyskinesia
13%
Risperidone
13%
Suicide
13%
Sleep
13%
Major Depressive Disorder
12%
Clinical Trials
12%
Inpatients
12%
Brain-Derived Neurotrophic Factor
11%
Sexual and Gender Minorities
11%
Bipolar Disorder
11%
Violence
11%
Suicidal Ideation
11%
Child
10%
Quetiapine Fumarate
9%
Perphenazine
9%
Psychology
8%
African Americans
8%
Transgender Persons
8%
Randomized Controlled Trials
8%
Mental Disorders
8%
Clozapine
8%
Placebos
7%
Quality of Life
7%
Anxiety
7%
Substance-Related Disorders
7%
Physicians
7%
Systematic Reviews
7%
Haloperidol
7%
Population
7%
Students
6%
Pharmaceutical Preparations
6%
Health
6%
Antidepressive Agents
6%
ziprasidone
6%
Cognition
6%
Brain
6%
Education
6%
Multiple Sclerosis
6%
Veterans
6%
Child Psychiatry
5%
Outpatients
5%
Adolescent Psychiatry
5%
Aripiprazole
5%
Delivery of Health Care
5%
Prefrontal Cortex
5%
Biomarkers
5%
Paternal Age
5%
Leukocyte Count
5%
Hippocampus
5%
Risk Assessment
5%
Inflammation
5%
Social Sciences
mental health
9%
adolescent
6%
schizophrenia
6%
psychiatry
6%
multiple sclerosis
6%
health
6%
violence
5%
mental illness
5%
evaluation
5%
sleep
5%